IHI JU calls 9 en 10 (2025)

Research

Funding organisation:

Europese Commissie

What?

The Innovative Health Initiative Joint Undertaking (IHI JU) is a partnership for health research and innovation between the EU and Europe’s life science industries. It aims to enable the cross-sectoral integration of technologies, know-how, products, services and workflows for people-centred healthcare. Its ambition is to support the delivery of timely and well-substantiated prevention, diagnosis, and treatment. The partnership aims to help keep EU citizens in good health, decrease disease burden for patients, caregivers and healthcare professionals. It intends to contribute to the sustainability and resilience of healthcare systems and to the competitiveness of European health industries.

Who?

Every IHI project is formed by a collaborative public-private partnership consortium reflecting the integrative and cross-sectoral nature of the partnership. Scale is a key to success and is provided by the leveraging of IHI funding with industry contributions in the Full consortium.

Most IHI JU calls are two-stage calls and are devised as follows (infographic):

• Call launch: A pre-identified Industry consortium (optionally including contributing partners) aligns itself around a real challenge in health care, agrees to work together (across sectors) and commits resources
• Stage 1: Applicant consortia (research organisations, patient organisations, SMEs, other healthcare stakeholders etc.) propose new ideas to address the challenge
• Stage 2: The first ranked Applicant consortium is invited to prepare and submit a 'Full proposal' to be evaluated (go/no go) together with the pre-identified Industry consortium

The Full consortium consists of the pre-identified Industry consortium and the selected Applicant consortium. Additional partners could also join the consortium during or after the granting phase via amendments.

The pre-identified consortium:

• is responsible for the 45% in-kind contribution;
• is the main drivers of the topic definition;
• identifies their in-kind contributions through expertise and assets listed in the topic text;
• cannot participate with the applicant consortium.

Applicant consortia:

• are not involved in the topic definition;
• can be eligible for funding;
• do not contact the pre-identified Industry consortium during the application process;
• consist of at least 1 organisation from an EU Member State and 2 organisations from different Member states or Associated Countries.

Application?

Call 9 (launched early 2025)
IHI call 9 will be a single-stage, applicant driven call with five topics (T) aligned with the five specific objectives (SO) set out in the IHI Strategic Research and Innovation Agenda (SRIA). For this call, the IHI JU wants applicants to explore the SRIA and identify untapped opportunities that could be transformed into public-private projects through IHI. The IHI call 9 topics are:

• T1 (SO1): contribute towards a better understanding of the determinants of health and priority disease areas;
• T2 (SO2): integrate fragmented health research & innovation efforts bringing together health industry sectors and other stakeholders, focusing on unmet public health needs, to enable the development of tools, data, platforms, technologies & processes for improved prediction, prevention, interception, diagnosis, treatment and management of diseases, meeting the needs of end-users;
• T3 (SO3): demonstrate the feasibility of people-centred, integrated healthcare solutions;
• T4 (SO4): exploit the full potential of digitalisation and data exchange in healthcare;
• T5 (SO5): enable the development of new and improved evaluation methodologies and models for a comprehensive assessment of the added value of innovative and integrated healthcare solutions.

Call 10 (launched early 2025)
IHI call 10 will be a standard, two-stage call for proposals with the following topics:

• Digital label: one source of comprehensive information for medical technology products
• Safeguarding innovation in secondary use of health data in the European Health Data Space (EHDS)
• Per- and poly-fluoroalkyl substance (PFAS) exposure, emissions, and end of life management in the healthcare sector

More information?

IHI will hold info sessions on both calls early 2025. These will cover the topics, IHI rules and procedures, and, for call 9, financial aspects of the proposal.

Publication call texts
IHI JU’s Strategic Research and Innovation Agenda (SRIA)

Contact Hasselt University?

E-mail ward.ceunen@uhasselt.be

Tel. +3211268945